慢性乙型肝炎感染患者的死亡率:慢性肝炎队列研究(CHeCS)
该研究分析2006年1月1日至2013年12月31日慢性乙型肝炎队列研究(CHeCS)中4389例患者,平均随访5.38年,492例(11%)死亡,平均死亡年龄59.8岁,比美国一般人群年轻14岁;全因死亡相对危险度RR=1.85(95%CI 1.851-1.857),肝病相关死亡RR=15.91(95%CI 15.81-16.01);仅19%死亡证明报告乙型肝炎。
要点
- 慢性乙型肝炎患者平均死亡年龄59.8岁,比美国一般人群年轻14岁。
- 全因死亡RR=1.85(95%CI 1.851-1.857),肝病相关死亡RR=15.91(95%CI 15.81-16.01)。
- 仅19%慢性乙型肝炎死亡者和40%肝病死亡者死亡证明报告乙型肝炎。
核心结论
- 与一般人群相比,慢性乙型肝炎患者死亡年龄更年轻,全因死亡率和肝病相关死亡率更高。
- 死亡证明低估了慢性乙型肝炎的真实死亡率。
研究设计与样本
- 分析慢性肝炎队列研究(CHeCS)中2006年1月1日至2013年12月31日就诊的慢性乙型肝炎患者数据。
- 比较CHeCS慢性乙型肝炎死亡者与美国多死因档案(MCOD)死亡者的总体和死因别死亡率及平均死亡年龄。
主要发现
- 4389例慢性乙型肝炎患者平均随访5.38年,492例(11%)死亡,死亡者平均随访3.00年。
- 死亡者较存活者更年长,白人占40.6%、非裔美国人占27.1%、男性占74.2%,肝硬化占59.8%、糖尿病占27.2%、酒精滥用占17.7%、肝细胞癌占17.5%、肝移植占5.7%;存活者亚洲人占48.8%(所有P < .001)。
- 慢性乙型肝炎患者平均死亡年龄59.8岁,比美国一般人群年轻14岁。
- 全因死亡RR=1.85(95%CI 1.851-1.857),肝病相关死亡RR=15.91(95%CI 15.81-16.01)。
- 仅19%慢性乙型肝炎死亡者和40%肝病死亡者死亡证明报告乙型肝炎。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: According to death certificates, approximately 1800 persons die from hepatitis B annually in the United States; however, this figure may underestimate true mortality from chronic hepatitis B (CHB). METHODS: We analyzed data from CHB patients seen in the Chronic Hepatitis Cohort Study (CHeCS) between 1 January 2006 and 31 December 2013. We compared overall and cause-specific death rates and mean ages at death between CHeCS CHB decedents and U.S. decedents from the Multiple Cause of Death (MCOD) file. RESULTS: Of 4389 CHB patients followed for a mean of 5.38 years, 492 (11%) CHB patients died after a mean follow-up of 3.00 years. Compared to survivors, decedents were older, more likely to be White (40.6%), African-American (27.1%), or male (74.2%); and more likely to have had cirrhosis (59.8%), diabetes (27.2%), alcohol abuse (17.7%), hepatocellular carcinoma (17.5%), or a liver transplant (5.7%); whereas survivors were more likely to be Asian (48.8%; all P < .001). CHB patients died at an average age of 59.8 years-14 years younger than the general U.S. population-and at higher rates for all causes (relative risk [RR] = 1.85, 95% confidence interval [CI], 1.851-1.857) and liver-related causes (RR = 15.91, 95% CI, 15.81-16.01). Only 19% of CHB decedents and 40% of those dying of liver disease had hepatitis B reported on their death certificates. CONCLUSIONS: Compared to the general population, CHB patients die at younger ages and higher rates from all causes and liver-related causes. Death certificates underrepresent the true mortality from CHB.
引用
- Bixler D, Zhong Y, Ly KN, et al. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019. PMID: 30060032. doi:10.1093/cid/ciy598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。